2017 Will Bring Premium Rate Increases Under ACA

Share this content:
2017 Will Bring Premium Rate Increases Under ACA
2017 Will Bring Premium Rate Increases Under ACA

FRIDAY, June 24, 2016 (HealthDay News) -- Health insurance premiums under the Affordable Care Act will rise in 2017, analysts and insurance brokers say.

The rate hikes will mainly affect the millions who pay all of the cost of health insurance out of their own pockets -- or a sizable portion of it, they explained.

Buyers with modest incomes, $29,700 to $35,640 for an individual, may qualify for federal subsidies to help lower their monthly health plan premiums if they enroll through HealthCare.gov or their state insurance marketplace. But they don't get as much financial help as low-income earners, and may feel the pinch of higher rates. Consumers earning upwards of $47,520 for an individual will certainly be affected. They can shop for health insurance either on or off the marketplaces established as part of the Affordable Care Act, but they'll pay the entire premium themselves, the experts said.

Low-income Americans who qualify for federal tax credits toward all or most of their health plan premiums may fare best. "When premiums come in higher, low-income people are insulated from those increases because the tax credits wind up being larger," Bradley Herring, Ph.D., an associate professor of health economics at Johns Hopkins University in Baltimore, told HealthDay. "But if you're not low-income then, no, you actually will face those high premium increases."

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell ...

Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

ASH: AAVD Beats ABVD for Advanced Hodgkin's Lymphoma

ASH: A+AVD Beats ABVD for Advanced Hodgkin's Lymphoma

Lower combined risk of progression, death, or noncomplete response with A+AVD

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia ...

Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels

is free, fast, and customized just for you!

Already a member?

Sign In Now »